A Prospective, Multicenter, Registry of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries (LEVANT 2 Safety Registry)
Latest Information Update: 06 Jun 2020
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions
- Acronyms LEVANT 2
- Sponsors CR Bard
- 19 May 2020 Status changed from active, no longer recruiting to completed.
- 13 Nov 2017 Planned End Date changed from 1 Sep 2018 to 1 Jun 2019.
- 22 Mar 2016 New trial record